A case report of biclonal immunoglobulin D lambda/lambda multiple myeloma in patient with liver echinococcosis

Biochem Med (Zagreb). 2024 Jun 15;34(2):020801. doi: 10.11613/BM.2024.020801. Epub 2024 Apr 15.

Abstract

Less than 2% of all symptomatic multiple myeloma (MM) has immunoglobulin D (IgD) as monoclonal protein. Biclonal gammopathy is much rarer. At the time of diagnosis, disease is often in advanced stage, including renal failure, anemia, hypercalcemia and lytic bone lesions. Due to the rarity of myeloma itself, but also due to the fact that anti-IgD antisera is not used in routine practice, there are only a few reports of IgD MM described in the literature. This case report describes a patient with IgD lambda MM with anemia and renal failure. Anemia, renal failure, and > 80 percent plasma cells in bone biopsy in our patient with IgD lambda MM meets International Myeloma Working Group criteria for diagnosis of MM. The patient clinical course was similar to other patients with IgD MM. The final result of serum protein immunofixation (s-IFE) showed IgD lambda and free lambda monoclonal bands. To prevent misdiagnosis, it is necessary to use anti-IgD and anti-IgE antisera whenever the serum protein immunofixation with IgA, IgM, IgG, kappa and lambda antiserums shows a kappa or lambda monoclonal band without monoclonal band in heavy chain.

Keywords: immunoglobulin D; monoclonal gammopathy; multiple myeloma; serum protein immunofixation.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Immunoglobulin D* / blood
  • Immunoglobulin lambda-Chains* / blood
  • Male
  • Middle Aged
  • Multiple Myeloma* / complications
  • Multiple Myeloma* / diagnosis

Substances

  • Immunoglobulin lambda-Chains
  • Immunoglobulin D